Apoptosis in the skeletal muscle of untreated children with juvenile dermatomyositis: impact of duration of untreated disease.

[1]  C. Langman,et al.  RANKL:osteoprotegerin ratio and bone mineral density in children with untreated juvenile dermatomyositis. , 2007, Arthritis and rheumatism.

[2]  B. Strotman,et al.  Nuclear translocation of EndoG at the initiation of disuse muscle atrophy and apoptosis is specific to myonuclei. , 2006, American journal of physiology. Regulatory, integrative and comparative physiology.

[3]  A. Dyer,et al.  Duration of illness is an important variable for untreated children with juvenile dermatomyositis. , 2006, The Journal of pediatrics.

[4]  R. Frye,et al.  TRAIL-expressing T cells induce apoptosis of vascular smooth muscle cells in the atherosclerotic plaque , 2006, The Journal of experimental medicine.

[5]  A. Dyer,et al.  History of infection before the onset of juvenile dermatomyositis: results from the National Institute of Arthritis and Musculoskeletal and Skin Diseases Research Registry. , 2005, Arthritis and rheumatism.

[6]  A. Dyer,et al.  Skin involvement in juvenile dermatomyositis is associated with loss of end row nailfold capillary loops. , 2004, The Journal of rheumatology.

[7]  M. Kawachi,et al.  Oligoclonal expansion of circulating and tissue‐infiltrating CD8+ T Cells with killer/effector phenotypes in juvenile dermatomyositis syndrome , 2004, Clinical and experimental immunology.

[8]  L. McLoon,et al.  Continuous myofiber remodeling in uninjured extraocular myofibers: Myonuclear turnover and evidence for apoptosis , 2004, Muscle & nerve.

[9]  A. Dyer,et al.  US incidence of juvenile dermatomyositis, 1995-1998: results from the National Institute of Arthritis and Musculoskeletal and Skin Diseases Registry. , 2003, Arthritis and rheumatism.

[10]  R. Bode,et al.  Disease activity score for children with juvenile dermatomyositis: reliability and validity evidence. , 2003, Arthritis and rheumatism.

[11]  L. Pachman,et al.  Expression of TNFα by muscle fibers in biopsies from children with untreated juvenile dermatomyositis : Association with the TNFα-308A allele , 2001 .

[12]  L. Pachman,et al.  Expression of TNFalpha by muscle fibers in biopsies from children with untreated juvenile dermatomyositis: association with the TNFalpha-308A allele. , 2001, Clinical immunology.

[13]  L. Pachman,et al.  TNFα-308A allele in juvenile dermatomyositis: Association with increased production of tumor necrosis factor α, disease duration, and pathologic calcifications , 2000 .

[14]  K. Nagaraju,et al.  The Inhibition of Apoptosis in Myositis and in Normal Muscle Cells1 , 2000, The Journal of Immunology.

[15]  L. Pachman,et al.  TNFalpha-308A allele in juvenile dermatomyositis: association with increased production of tumor necrosis factor alpha, disease duration, and pathologic calcifications. , 2000, Arthritis and rheumatism.

[16]  J. Puck,et al.  Autoimmune lymphoproliferative syndrome, a disorder of apoptosis. , 1999, Current opinion in pediatrics.

[17]  J. Puck,et al.  Autoimmune lymphoproliferative syndrome with defective Fas: genotype influences penetrance. , 1999, American journal of human genetics.

[18]  V. Dixit,et al.  Apoptosis control by death and decoy receptors. , 1999, Current opinion in cell biology.

[19]  A. Nagai,et al.  Fas and Fas ligand interaction induces apoptosis in inflammatory myopathies: CD4+ T cells cause muscle cell injury directly in polymyositis. , 1999, Arthritis and rheumatism.

[20]  K. Roth,et al.  In situ immunodetection of activated caspase-3 in apoptotic neurons in the developing nervous system , 1998, Cell Death and Differentiation.

[21]  John C. Lee,et al.  Osteoprotegerin Is a Receptor for the Cytotoxic Ligand TRAIL* , 1998, The Journal of Biological Chemistry.

[22]  S. Srinivasula,et al.  Cytochrome c and dATP-Dependent Formation of Apaf-1/Caspase-9 Complex Initiates an Apoptotic Protease Cascade , 1997, Cell.

[23]  I. Ferrer,et al.  Apoptosis is not the mechanism of cell death of muscle fibers in human muscular dystrophies and inflammatory myopathies , 1997, Muscle & nerve.

[24]  G. Sobue,et al.  Expression of Fas antigen is not associated with apoptosis in human myopathies , 1997, Muscle & nerve.

[25]  P. Krammer,et al.  Interleukin 1β-converting Enzyme Related Proteases/Caspases Are Involved in TRAIL-induced Apoptosis of Myeloma and Leukemia Cells , 1997, The Journal of cell biology.

[26]  A. Peña,et al.  Differences in the intrinsic capacity of peripheral blood mononuclear cells to produce tumor necrosis factor alpha and beta in patients with inflammatory bowel disease and healthy controls. , 1995, Scandinavian journal of gastroenterology.

[27]  R. Hohlfeld,et al.  Cellular mechanisms in inflammatory myopathies. , 1993, Bailliere's clinical neurology.

[28]  S. Ben‐Sasson,et al.  Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation , 1992, The Journal of cell biology.

[29]  V. Dubowitz,et al.  Nature of the mononuclear infiltrate and the mechanism of muscle damage in juvenile dermatomyositis and Duchenne muscular dystrophy , 1990, Journal of the Neurological Sciences.

[30]  A. Engel,et al.  Mononuclear cells in myopathies: quantitation of functionally distinct subsets, recognition of antigen-specific cell-mediated cytotoxicity in some diseases, and implications for the pathogenesis of the different inflammatory myopathies. , 1986, Human pathology.

[31]  A. Bohan,et al.  Polymyositis and dermatomyositis (second of two parts). , 1975, The New England journal of medicine.

[32]  A. Bohan,et al.  Polymyositis and dermatomyositis (second of two parts). , 1975 .